Rifampin
Edina Avdic, Pharm.D.
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
All forms of tuberculosis.
Treatment of asymptomatic carriers of
Neisseria meningitidis
to eliminate meningococci from the nasopharynx.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Prosthetic valve endocarditis
caused by staphylococci in combination with other agents (e.g.
oxacillin
/
nafcillin
,
vancomycin
) after blood cultures have cleared.
Prosthetic joint infections
following debridement and retention of the prosthesis or 1-stage exchange.
Meningitis caused by penicillin and ceftriaxone resistant
S. pneumoniae
Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
Brucellosis
Bartonella
infections
Q-fever
and
rickettsial
infections
Cutaneous
leishmaniasis
Legionella
infections
Anthrax
infections
NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved